Education
About Us
Working with TipRanks
Follow Us
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
Arm 1 - Dehydratech-Cbd Alone, Arm 2 - Dehydratech-Semaglutide Alone, Arm 3 - Dehydratech-Cbd In Combination With Dehydratech-Semaglutide, Arm 4 - Rybelsus Medication (Semaglutide) Alone, Arm 5- Tirzepatide
Type2diabetes
Phase I
Active Not Recruiting
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Oct 16, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lexaria Bioscience (LEXX) have in its pipeline
LEXX is currently developing the following drugs: Arm 1 - Dehydratech-Cbd Alone, Arm 2 - Dehydratech-Semaglutide Alone, Arm 3 - Dehydratech-Cbd In Combination With Dehydratech-Semaglutide, Arm 4 - Rybelsus Medication (Semaglutide) Alone, Arm 5- Tirzepatide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.